Lacosamide 62332-0173-10
- Manufacturer
- Alembic Pharmaceuticals Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- March 18, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA204974
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 150 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
62332-0173-10Selected100 BLISTER PACK in 1 CARTON (62332-173-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK
Other packages for this product(3)
30 TABLET, FILM COATED in 1 BOTTLE (62332-173-30)
60 TABLET, FILM COATED in 1 BOTTLE (62332-173-60)
1000 TABLET, FILM COATED in 1 BOTTLE (62332-173-91)